Tumor-Infiltrating Lymphocytes: A Promising Biomarker in Breast Cancer

被引：30

作者：

Heppner, Barbara Ingold ^{[1
]}

Loibl, Sibylle ^{[2
,3
]}

Denkert, Carsten ^{[1
,4
]}

机构：

[1] Charite, Inst Pathol, D-13353 Berlin, Germany

[2] German Breast Grp GBG Forsch GmbH, Neu Isenburg, Germany

[3] Sana Klinikum Offenbach, Offenbach, Germany

[4] German Canc Consortium DKTK, Berlin, Germany

来源：

BREAST CARE | 2016年 / 11卷 / 02期

关键词：

Breast cancer; Tumor-infiltrating lymphocytes; Adjuvant; Neoadjuvant; Pathological complete response; NEOADJUVANT CHEMOTHERAPY; PROGNOSTIC VALUE; PREDICTIVE-VALUE; PRIMARY THERAPY; TRASTUZUMAB; CARCINOMA; CONSENSUS; ANTIBODY;

D O I：

10.1159/000444357

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

There is clear evidence that the immune system plays an essential role in tumor defense. By determining tumor-infiltrating lymphocytes (TILs), the individual immunological response becomes more apparent and measurable. In breast cancer, high levels of TILs are associated with a more favorable clinical course. In this review, we describe how TILs are determined with emphasis on daily routine diagnostics. We further discuss their impact as a prognostic and predictive biomarker in the neoadjuvant and adjuvant therapy setting as well as in residual disease. We also discuss their potential future implications on further stratifying prognostic subgroups of breast cancer, thereby possibly influencing future therapy considerations. (C) 2016 S. Karger GmbH, Freiburg

引用

页码：96 / 100

页数：5

共 50 条

[1] Relevance of tumor-infiltrating lymphocytes in breast cancer
Sathana Dushyanthen
Paul A. Beavis
Peter Savas
Zhi Ling Teo
Chenhao Zhou
Mariam Mansour
Phillip K. Darcy
Sherene Loi
[J]. BMC Medicine, 13
[2] Relevance of tumor-infiltrating lymphocytes in breast cancer
Dushyanthen, Sathana
Beavis, Paul A.
Savas, Peter
Teo, Zhi Ling
Zhou, Chenhao
Mansour, Mariam
Darcy, Phillip K.
Loi, Sherene
[J]. BMC MEDICINE, 2015, 13
[3] Emerging measurements for tumor-infiltrating lymphocytes in breast cancer
Wu, Rongrong
Horimoto, Yoshiya
Oshi, Masanori
Benesch, Matthew G. K.
Khoury, Thaer
Takabe, Kazuaki
Ishikawa, Takashi
[J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2024, 54 (06) : 620 - 629
[4] Clinical significance of tumor-infiltrating lymphocytes in breast cancer
Stanton, Sasha E.
Disis, Mary L.
[J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2016, 4
[5] Tumor-infiltrating lymphocytes in triple negative breast cancer
Zakhartseva, L. M.
Yanovytska, M. O.
[J]. PATHOLOGIA, 2020, (03): : 287 - 294
[6] The journey of tumor-infiltrating lymphocytes as a biomarker in breast cancer: clinical utility in an era of checkpoint inhibition
Loi, S.
Michiels, S.
Adams, S.
Loibl, S.
Budczies, J.
Denkert, C.
Salgado, R.
[J]. ANNALS OF ONCOLOGY, 2021, 32 (10) : 1236 - 1244
[7] Tumor-Infiltrating Lymphocytes (TILs) as a Biomarker of Abscopal Effect of Cryoablation in Breast Cancer: A Pilot Study
Sonia Y. Khan
Michael W. Melkus
Fahmida Rasha
Maribel Castro
Victoria Chu
Luis Brandi
Hafiz Khan
Harvinder Singh Gill
Kevin Pruitt
Rakhshanda Layeequr Rahman
[J]. Annals of Surgical Oncology, 2022, 29 : 2914 - 2925
[8] Tumor-Infiltrating Lymphocytes (TILs) as a Biomarker of Abscopal Effect of Cryoablation in Breast Cancer: A Pilot Study
Khan, Sonia Y.
Melkus, Michael W.
Rasha, Fahmida
Castro, Maribel
Chu, Victoria
Brandi, Luis
Khan, Hafiz
Gill, Harvinder Singh
Pruitt, Kevin
Layeequr Rahman, Rakhshanda
[J]. ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (05) : 2914 - 2925
[9] Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer: A Biomarker for Use Beyond Prognosis?
Tsoutsou, Pelagia G.
Bourhis, Jean
Coukos, George
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (11) : 1297 - +
[10] Tumor-infiltrating lymphocytes predict prognosis in early breast cancer
Mao, Y.
Qu, Q.
Wu, J.
Chen, X.
Huang, O.
Shen, K.
[J]. BREAST, 2015, 24 : S101 - S101

← 1 2 3 4 5 →